Director Han Yusheng Buys $6.18M in Open Market Shares
BNR has more than doubled off its 52-week low of $3.14 on light trading volume (0.3× avg).
Summary
Burning Rock Biotech Director Han Yusheng made a significant open market purchase of $6.18 million in company shares, signaling strong insider confidence.
Key Events · Ownership and Investor Activity · BNR
-
Director's Significant Investment
Han Yusheng, a Director, purchased $6,182,172 worth of shares in open market transactions between June 11 and June 26, 2026.
-
Strong Insider Conviction
This substantial purchase, representing over 7% of the company's market capitalization, indicates strong confidence from a key insider, particularly after recent mixed financial reports.
Analysis · BNR · Industrial Applications And Services
Director Han Yusheng's substantial open market purchase of over $6.18 million in company stock signals strong conviction. This significant investment, made across multiple transactions, represents a notable portion of the company's market capitalization and comes after a recent 6-K filing reported a revenue decrease, suggesting the director sees value despite recent challenges.
How filings like this one have moved
In the 30 days to Sep 11, 2026, 42.6% of the 523 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.47%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, BNR was trading at $8.96 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $88M. The 52-week trading range was $3.14 to $41.72. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.